Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations
A Koyyada - Therapies, 2021 - Elsevier
The long-term use of proton pump inhibitors (PPIs) can lead to increased gastric pH,
hypochlorhydria and in some cases to achlorhydria when compared to other acid …
hypochlorhydria and in some cases to achlorhydria when compared to other acid …
Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice
KY Ho, KA Gwee, YK Cheng, KH Yoon… - Journal of pain …, 2018 - Taylor & Francis
COX2-selective and nonselective (ns) nonsteroidal anti-inflammatory drugs (NSAIDs) are
widely used for chronic pain management. There are marked differences in the risk of …
widely used for chronic pain management. There are marked differences in the risk of …
Physiologic, pathophysiologic, and pharmacologic regulation of gastric acid secretion
ML Schubert - Current opinion in gastroenterology, 2017 - journals.lww.com
Current Opinion in Gastroenterology Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …
[PDF][PDF] Proton-pump inhibitor use and fracture risk: an updated systematic review and meta-analysis
Y Nassar, S Richter - J Bone Metab, 2018 - synapse.koreamed.org
Background: This study's objective was to evaluate the association between protonpump
inhibitor (PPI) use and bone fracture incidence and bone mineral density (BMD) by meta …
inhibitor (PPI) use and bone fracture incidence and bone mineral density (BMD) by meta …
A contemporary look at biomechanical models of myocardium
Understanding and predicting the mechanical behavior of myocardium under healthy and
pathophysiological conditions are vital to develo** novel cardiac therapies and promoting …
pathophysiological conditions are vital to develo** novel cardiac therapies and promoting …
Adverse events of proton pump inhibitors: potential mechanisms
A Corsonello, F Lattanzio, S Bustacchini… - Current drug …, 2018 - benthamdirect.com
Objective: We aimed at summarizing current evidence about mechanisms for potentially
harmful effects of Proton Pump Inhibitors (PPIs). Methods: A Pubmed search was performed …
harmful effects of Proton Pump Inhibitors (PPIs). Methods: A Pubmed search was performed …
National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017
Abstract Objectives In the United States, proton pump inhibitors (PPIs) are one of the most
commonly prescribed classes of drugs, but contemporary data on national-level utilization …
commonly prescribed classes of drugs, but contemporary data on national-level utilization …
Current management of gastro-oesophageal reflux disease—treatment costs, safety profile, and effectiveness: a narrative review
T Lata, J Trautman, P Townend… - Gastroenterology …, 2023 - academic.oup.com
Background The purpose of this study was to review the current management of gastro-
oesophageal reflux disease (GORD), including treatment costs, safety profile and …
oesophageal reflux disease (GORD), including treatment costs, safety profile and …
Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials
Background Although randomized controlled trials (RCTs) have suggested a non-significant
increased risk of stroke among proton pump inhibitor (PPI) users, the association has not …
increased risk of stroke among proton pump inhibitor (PPI) users, the association has not …
[HTML][HTML] Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction
Proton pump inhibitors (PPIs) are widely used drugs that may increase the cardiovascular
risk by mechanisms not entirely known. While PPIs increase asymmetric dimethylarginine …
risk by mechanisms not entirely known. While PPIs increase asymmetric dimethylarginine …